Browse the full management transaction log of 바이오플러스, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Market capitalisation: €309.5bn. The latest transaction was filed on 2 April 2026 — Purchase. Among the most active insiders: 정현규. All data is accessible without an account.